What Redesign Health does

Redesign Health is a global venture and applied technology platform founded in 2018 that builds and backs next-generation healthcare companies through AI-native venture capital and buyout strategies. The firm operates as a two-sided marketplace: on one side, exceptional healthcare founders are recruited through a direct inbox ([email protected]) and the firm's proprietary AI knowledge graph; on the other, marquee healthcare institutions — Mayo Clinic, Cedars-Sinai, UPMC Enterprises, DaVita, and Singapore General Hospital — act as co-developers, clinical testbeds, and launch partners for portfolio companies. Sovereign and institutional capital partners such as Sanabil Investments extend this model regionally into Saudi Arabia, India, and Asia. Since 2018, Redesign Health has supported over 60 healthcare companies that collectively serve more than 15 million patients and have raised over $1.5 billion in cumulative capital.

The core technology is an internal AI knowledge graph built on millions of hours of internal expert research and hundreds of thousands of institutional and decision-maker relationships, which humans and AI agents traverse collaboratively to match founders with institutions, capital with opportunities, and technology with solvable problems. The firm describes its venture process as a "repeated computational game whose inputs are knowledge and relationships," and treats experimentation and technical leverage as core operating principles. Around this substrate sits a portfolio of independently operating product companies across applied AI platforms (Anomaly Insights, STARFIRE, Nuxera AI/SERA), patient engagement and workforce infrastructure (Gravity Rail, Worki), clinical workflow and care delivery (Corvus, Linea), financial infrastructure (Thrivory/ThriveNow API), and specialty care services (Noma Therapy), supported by frontier-model partnerships with Anthropic, OpenAI, Google, Microsoft, and AWS and a regional sub-brand (Sanabil Venture Studio by Redesign Health) in Saudi Arabia.

The business model combines equity returns from venture creation and buyouts with management-fee economics on deployed capital. Redesign Health is not a SaaS company and does not publicly disclose pricing; deal terms are negotiated bilaterally with founders, institutions, and portfolio companies. Disclosed capital activity includes a $65 million Series C in September 2022 led by General Catalyst and a $175 million raise covered by the Wall Street Journal, alongside earlier $250M+ rounds, with current geographic reach spanning New York, Los Angeles, Riyadh, and Bengaluru offices plus the Singapore General Hospital partnership. Notable portfolio outcomes include Lively's acquisition by GN Hearing for DKK 625 million (December 2021) and DUOS' reported $130 million raise to scale AI-driven payer and senior care partnerships.

Name

Redesign Health

Legal name

Redesign Health Inc.

Website

https://redesignhealth.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

101–250 employees

Short description

Redesign Health is an AI-native global venture builder that creates and scales healthcare companies through venture capital and buyout strategies, partnering with founders and marquee institutions (Mayo Clinic, Cedars-Sinai, UPMC, DaVita) across the US, Saudi Arabia, India, and Asia.

Ownership category

akta.pro rank

Product category

Healthcare Venture Building

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Social Sciences and Humanities (54172), Residential Remodelers (236118)

SIC

Services-Computer Integrated Systems Design (7373), Services-Prepackaged Software (7372)

akta.pro primary industry

Organizational Change & Transformation Coaching (EDABANAG)

akta.pro secondary industries

Change Management & Transformation (Org/HR) (BPACAJAD), Health Systems Strengthening & Primary Care Development (HLAJAKAJ), Marketing Transformation & Change Management (MPAAAFAO), Health Access & Social Care Innovations (Community Health, Telehealth for Underserved) (BPAGALAG)

Keywords

• Healthcare venture building
• AI-native venture capital
• Digital health platforms
• Healthcare startup studio
• Applied AI healthcare

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Equity Returns from AI-Native Venture Builds: Redesign Health builds next-generation healthcare companies from scratch, taking equity stakes; returns come from long-term value creation in portfolio companies as they grow and exit. Since 2018, portfolio companies have raised over $1.5 billion.
2. Buyout Strategy Returns: In addition to venture creation, Redesign Health pursues buyout strategies of existing businesses, generating returns through operational improvement and exit events.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

Redesign Health is a global venture and applied technology platform that builds and backs next-generation healthcare companies through AI-native venture capital and buyout strategies. It partners with exceptional founders and existing businesses, leveraging a proprietary AI knowledge graph and marquee institutional relationships to co-develop, validate, and scale healthcare companies. Since 2018, it has launched and supported more than 60 healthcare companies that together have touched over 15 million patients and raised more than $1.5 billion.

Product overview

Redesign Health operates a unified AI-native venture and applied technology platform (the Redesign Health Platform) rather than a single end-user product. Its core platform centers on an internal AI Knowledge Graph—built on millions of hours of expert research and hundreds of thousands of institutional relationships—which powers both internal investment decisions and the technical foundation that portfolio companies plug into from investment through exit. Around this platform, Redesign Health builds, backs, and scales a portfolio of healthcare companies via AI-native venture capital and buyout strategies, including applied AI platforms (Anomaly Insights, STARFIRE, Nuxera AI/SERA), patient engagement and workforce infrastructure (Gravity Rail, Worki), clinical workflow and care delivery products (Corvus, Linea), financial infrastructure (Thrivory/ThriveNow API), and specialty care services (Noma Therapy), as well as regional venture studios such as the Sanabil Venture Studio by Redesign Health. The platform architecture therefore consists of a shared AI/knowledge-graph core serving a portfolio of independently operating product companies, rather than modular add-ons to a single product.

Differentiator

Problem solved

Functional benefit

Products and services

• Redesign Health Platform A global venture and applied technology platform that builds and backs next-generation healthcare companies through AI-native venture capital and buyout strategies, supported by a proprietary AI knowledge graph, marquee institutional relationships, and a commercial and technical apparatus deploying from investment through exit.
• Redesign Health AI Knowledge Graph Internal AI knowledge graph built on millions of hours of internal expert research and hundreds of thousands of relationships with healthcare institutions and decision makers, used to match founders with institutions, capital with opportunities, and technology with solvable problems.
• Corvus A digital health company that optimizes surgical referral management by automating administrative workflows and applying AI to assess patient eligibility, streamline triage, and improve operating room utilization. Targeted at health systems and surgical practices, with strategic involvement from Mayo Clinic.
• STARFIRE An agentic commercial intelligence platform for the life sciences industry that uses AI-driven agents to automate complex commercial, value, and market access analyses for pharmaceutical companies. Targeted at pharma and life sciences commercial, value, and market access teams.
• Gravity Rail An AI-powered, model-agnostic patient engagement platform that enables healthcare organizations to design and run multi-channel engagement workflows across phone, SMS, email, web, and messaging without code or external vendors, under HIPAA compliance. Targeted at healthcare provider organizations.
• Worki A healthcare workforce infrastructure platform that uses an AI-driven task-role architecture to unify fragmented workforce data and identify where AI agents can augment or automate tasks while maintaining human oversight. Targeted at health systems and other regulated industries.
• Nuxera AI (SERA) A Saudi healthtech startup whose SERA AI platform enhances clinical workflows and decision-making for healthcare providers in Saudi Arabia. Targeted at healthcare providers in the Kingdom of Saudi Arabia.
• Linea An AI-backed care platform for congestive heart failure that delivers predictive insights and streamlined workflows across care settings. Co-developed with DaVita Venture Group for chronic kidney and heart failure care.
• Thrivory (ThriveNow API) A healthcare AI company that provides real-time healthcare payments infrastructure via the ThriveNow API, enabling instant, non-recourse claim settlement embedded in electronic health record and practice management workflows.
• Anomaly Insights An AI-powered payer intelligence platform that uses AI and machine learning to analyze payer behavior, policy shifts, and claim adjudication patterns, helping healthcare providers identify revenue lost to denials, underpayments, and other payment deviations.
• Noma Therapy A virtual mental health platform offering evidence-based, insurance-covered, virtual ketamine-assisted psychotherapy. Targeted at patients in Colorado and Texas with planned geographic expansion.
• Sanabil Venture Studio by Redesign Health A regional venture studio partnership between Sanabil Investments and Redesign Health that backs AI-native healthtech startups targeting the Saudi healthcare market, such as Nuxera AI's SERA platform.

Quantifiable outcome

• Touched the lives of more than 15 million patients
• +4 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability12 records

Feature3 records

Partnerships

Twelve partnerships are on record, tiered flagship and core.

• Singapore General Hospital (SGH)flagshipStrategic or Co-development Partner · 1 December 2025Three-year collaboration formalized via MOU signed in December 2025 between SGH and Redesign Health Inc. Combines SGH's clinical expertise and hospital access with Redesign Health's institutional capital, AI-enabled platform, and domain expertise to co-develop digital health startups addressing ageing-in-place, chronic care, workforce productivity, and other national healthcare priorities across Asia and globally.
• Sanabil InvestmentsflagshipStrategic or Co-development Partner · 14 January 2025Sanabil Investments and Redesign Health announced a partnership (BusinessWire, January 2025) to accelerate healthcare innovation in Saudi Arabia, anchored by the Sanabil Venture Studio by Redesign Health. The partnership backs Saudi healthtech startups (e.g., Nuxera AI) and supports Redesign Health's Riyadh office and broader regional expansion.
• Mayo ClinicflagshipStrategic or Co-development PartnerMayo Clinic is listed in Redesign Health's "In collaboration with" section on the corporate website and has served as a strategic co-builder across multiple portfolio companies, including piloting Corvus across four surgical specialties. Mayo Clinic is also a backing party for portfolio launches such as Corvus.
• Cedars-SinaiflagshipStrategic or Co-development PartnerCedars-Sinai and Redesign Health launched an end-to-end digital health venture platform (per Fierce Healthcare coverage featured on the website), and Cedars-Sinai is listed in the firm's "In collaboration with" section as a marquee partner for co-developing healthcare companies.
• UPMC (UPMC Enterprises)flagshipStrategic or Co-development PartnerUPMC is listed in Redesign Health's "In collaboration with" section as a partner institution developing innovative healthcare solutions and supporting portfolio company development.
• DaVitaflagshipStrategic or Co-development PartnerDaVita is listed in Redesign Health's "In collaboration with" section and is the strategic co-developer/launch partner of portfolio company Linea, an AI-driven heart failure care platform that has reported a 50% reduction in hospital readmissions and 80% patient engagement rates in early results.
• AnthropicflagshipTechnology or IntegrationAnthropic is listed in the "In collaboration with" section on the Redesign Health corporate website as a marquee AI technology partner supporting the firm's AI-native operating model and portfolio company development.
• OpenAIflagshipTechnology or IntegrationOpenAI is listed in the "In collaboration with" section on the Redesign Health corporate website as a marquee AI technology partner underpinning the firm's AI-native venture operations and portfolio companies.
• GoogleflagshipTechnology or IntegrationGoogle is listed in the "In collaboration with" section on the Redesign Health corporate website as a marquee AI/cloud technology partner for the firm's AI-native platform and portfolio companies.
• MicrosoftflagshipTechnology or IntegrationMicrosoft is listed in the "In collaboration with" section on the Redesign Health corporate website as a marquee AI/cloud technology partner for the firm's AI-native operations and portfolio companies.
• Amazon Web Services (AWS)flagshipTechnology or IntegrationAWS is listed in the "In collaboration with" section on the Redesign Health corporate website as a marquee cloud infrastructure partner for the firm's AI-native platform and portfolio companies.
• General CatalystcoreStrategic or Co-development PartnerGeneral Catalyst is listed in the "In collaboration with" section on the Redesign Health corporate website, indicating a strategic peer/ecosystem relationship within healthcare venture and applied technology.

Scale indicators7 records

Recent moves8 records

Expansion highlights8 records

Direct peers

• Flagship Pioneering: Flagship Pioneering is a healthcare and biotech venture builder that creates and grows companies from internal concepts — a near-perfect analog to Redesign Health's venture-creation model, though Flagship's portfolio skews toward therapeutics and synthetic biology rather than digital health and care delivery.
• StartUp Health: StartUp Health is a global health innovation platform that supports a portfolio of healthcare founders through a long-term, multi-stage model. It mirrors Redesign Health's community-led, founder-supporting approach but operates more as an accelerator/network than a co-builder with equity stakes.
• Atomic (formerly Atomic Labs): Atomic is a venture studio that co-founds companies from scratch with a dedicated operating team, applying a structured playbook similar to Redesign Health's venture-build model. While Atomic spans multiple sectors, its stage and co-build mechanics are closely comparable.
• Pioneer Square Labs: Pioneer Square Labs is a Seattle-based venture studio that builds and launches startups alongside founders, mirroring Redesign Health's venture-creation playbook. It serves as a useful comparator for venture-studio economics and graduation rates.
• Science Inc. Science Inc. is a venture studio that builds, funds, and scales companies from inception, sharing Redesign Health's applied-platform approach to company creation. It offers a useful peer benchmark for venture-studio operating leverage.

Broad incumbents

• General Catalyst: General Catalyst is a large venture capital firm with deep healthcare exposure that has co-invested in Redesign Health (Series C lead) and is listed as a strategic partner. It is a broad incumbent in healthcare VC rather than a direct venture builder.
• Andreessen Horowitz (a16z Bio + Health): a16z Bio + Health is a dedicated healthcare and bio practice within a leading venture firm, backing companies across care delivery, biotech, and digital health. It is a broad incumbent competing for the same founders and institutions as Redesign Health.
• Khosla Ventures: Khosla Ventures is a venture firm with significant healthcare and applied-AI investing activity, frequently backing healthcare AI founders. It is a broad incumbent in the same deal ecosystem as Redesign Health.
• GV (Google Ventures): GV is the venture arm of Alphabet and a prolific healthcare and life-sciences investor, backing companies across digital health, biotech, and care delivery. It is a broad incumbent comparable in scale and stage to Redesign's late-stage bets.

Others

• Mayo Clinic Platform: Mayo Clinic Platform is Mayo Clinic's internal digital health venture arm, partnering with — and at times overlapping — Redesign Health as a co-builder. It is comparable as an institutional venture platform rather than a direct competitor, and an important ecosystem counterpart.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/redesign-health
• Xx.com/redesignhealth1

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries11 records

Funding overview

Funding rounds6 records

Investors15 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments29 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Redesign Health